Alligator Bioscience and Aptevo Therapeutics Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting

World News: . []

LUND Sweden and SEATTLE Nov 08 2018 GLOBE NEWSWIRE) -- Alligator Bioscience Nasdaq Stockholm: ATORX a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy and Aptevo Therapeutics Inc (Nasdaq: A PVO), a...

More news and information about Aptevo Therapeutics Inc.

Published By:

Globe Newswire: 05:00 GMT Friday 9th November 2018

Published: .

Search for other references to "alligator" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us